Format

Send to

Choose Destination
Adv Clin Chem. 2015;71:25-45. doi: 10.1016/bs.acc.2015.06.001. Epub 2015 Jun 26.

Polycystic Ovary Syndrome-Epigenetic Mechanisms and Aberrant MicroRNA.

Author information

1
Department of Endocrinology, University of Medicine and Pharmacy "Iuliu-Hatieganu", Cluj-Napoca, Romania.
2
Department of Endocrinology, University of Medicine and Pharmacy "Iuliu-Hatieganu", Cluj-Napoca, Romania. Electronic address: c_e_georgescu@yahoo.com.

Abstract

Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in women of reproductive age affecting various functions including reproduction and metabolism. This syndrome is associated with increased prevalence of subclinical cardiovascular disease as well as endometrial and ovarian cancer. This syndrome is highly heterogeneous and it is not yet clear which factors are responsible for the development of a particular phenotype. Current research has shown that the interaction of susceptible and protective genomic variants under the influence of environmental factors can modify the clinical presentation via epigenetic modifications. MicroRNA (miRNA) are regulators of gene expression. Altered miRNA expression has been associated with various diseases such as diabetes, insulin resistance, inflammation, and cancer. Several miRNA have been identified in PCOS. This review examines the role of epigenetics and miRNA in the pathophysiology of this complex disease process.

KEYWORDS:

DNA methylation; Epi-miRNA; Epigenetics; Polycystic ovary syndrome; miRNA

Comment in

PMID:
26411410
DOI:
10.1016/bs.acc.2015.06.001
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center